Early- and later-stage persistence with antiobesity medications: A retrospective cohort study
CONCLUSIONS: Later-stage persistence with AOM varies considerably based on the drug and the weight loss at 6 months.PMID:38053443 | DOI:10.1002/oby.23952
Source: Obesity - Category: Eating Disorders & Weight Management Authors: Hamlet Gasoyan Elizabeth R Pfoh Rebecca Schulte Phuc Le Michael B Rothberg Source Type: research
More News: Adipex | Bupropion | Eating Disorders & Weight Management | Electronic Health Records (EHR) | Obesity | Phentermine | Study | Topamax | Weight Loss | Wellbutrin